Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Морфоиммунологическая характеристика поражения костного мозга при диффузной В-клеточной крупноклеточной лимфоме
Морфоиммунологическая характеристика поражения костного мозга при диффузной В-клеточной крупноклеточной лимфоме
Е.В.Чигринова, А.И.Павловская, Н.Н.Тупицын. Морфоиммунологическая характеристика поражения костного мозга при диффузной В-клеточной крупноклеточной лимфоме. Онкология. 2006; 4: 8-16.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds.). World Health Organisation classification of tumours pathology and genetics of tumours of hematopoetic and lymphoid tissues. Lyon: IARC Press, 2001.
2. Feller AC, Diebold J. Histopathology of nodal and extranodal non-Hodgkin's lymphoma. Third, Completely Revised and Updated Edition. Berlin–Heidelberg–New York: Springer-Verlag, 2004.
3. Поддубная И.В. Иммунодиагностика гемобластозов. Клиническая онкогематол. М.: Медицина, 2001; c. 336–75.
4. Lopez-Guillermo A, Colomo L et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23 (12): 2797–804.
5. Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases. Br J Haematol 2004; 124 (2): 151–9.
6. Shipp M, Harrington D et al. A predictive model for aggressive NHL. N Engl J Med 1993; 329: 987–94.
7. Baar JW, De Jong D et al. Diffuse large B-cell non-Hodgkin lymphoma: the clinical relevance of histological subclassification. Br J Cancer 1999; 79: 2291–7.
8. Colomo Lluэ_s, Armando Lo_pez-Guillermo et al. Clinical impact of the differentiation profile assessed by immunophenotypingin patients with diffuse large B-cell lymphoma. Blood 2003; 101 (11): 78–84.
9. Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leuk Lymphoma 2003; 44 (Suppl. 3): S41–7.
10. Pescarmona E, De Sanctis V et al. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas. J Pathol 1997; 183 (3): 281–6.
11. Ohshima K, Kawasaki C, Muta H et al. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology 2001; 39 (2): 156–62.
12. Xu Y, McKenna RW, Doolittle JE et al. The t(14;18) in diffuse large B-cell lymphoma: correlation with germinal center-associated markers and clinical features. Appl Immunohistochem Mol Morphol 2005; 13 (2): 116–23.
13. Wright George, Bruce Tan et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. PNAS 2003; 100 (17): 9991–6.
14. Wu G, Keating A. Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma. Cancer 2006; 106 (2): 247–57.
15. Monti Stefano, Kerry J.Margaret A. Shipp et al.Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105 (5): 1851–61.
16. Бабичева Л.Г. Факторы прогноза при диффузной В-клеточной крупноклеточной лимфоме. Дис. ... канд. мед. наук. М.: ГУ РОНЦ им. Н.Н. Блохина РАМН, 2005.
17. Terol MJ, Tormo M, Martinez-Climent JA et al. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome. Ann Oncol 2003; 14: 467–74.
18. Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 2005; 106 (4): 1164–74.
19. Elstrom R, Liang Guan et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101 (10): 3875–6.
20. Bain BJ et al. Bone marrow pathology. Blackwell Science Ltd, London: 2001.
21. Bain BJ. Bone marrow trephine biopsy. J Clin Pathol 2001; 54: 737–42.
22. Чигринова Е.В., Павловская А.И., Тупицын Н.Н. Роль иммунофенотипирования в диагностике опухолевого поражения костного мозга при В-клеточных неходжкинских лимфомах. Иммунология гемопоэза. М.: Издательская группа ГУ РОНЦ им Н.Н.Блохина РАМН. 2006; с. 91–117.
23. Falko F, Quintanilla-Martinez L et al. Composite Low Grade B-Cell Lymphomas with Two Immunophenotypically Distinct Cell Populations Are True Biclonal Lymphomas. American Journal of Pathology 1999; 154 (6): 1857–66.
24. Тупицын Н.Н. Иммунологическая диагностика лимфом. Руководство по иммуногистохимической диагностике опухолей человека. М.: Титул, 2004; c. 246–73.
2. Feller AC, Diebold J. Histopathology of nodal and extranodal non-Hodgkin's lymphoma. Third, Completely Revised and Updated Edition. Berlin–Heidelberg–New York: Springer-Verlag, 2004.
3. Поддубная И.В. Иммунодиагностика гемобластозов. Клиническая онкогематол. М.: Медицина, 2001; c. 336–75.
4. Lopez-Guillermo A, Colomo L et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23 (12): 2797–804.
5. Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases. Br J Haematol 2004; 124 (2): 151–9.
6. Shipp M, Harrington D et al. A predictive model for aggressive NHL. N Engl J Med 1993; 329: 987–94.
7. Baar JW, De Jong D et al. Diffuse large B-cell non-Hodgkin lymphoma: the clinical relevance of histological subclassification. Br J Cancer 1999; 79: 2291–7.
8. Colomo Lluэ_s, Armando Lo_pez-Guillermo et al. Clinical impact of the differentiation profile assessed by immunophenotypingin patients with diffuse large B-cell lymphoma. Blood 2003; 101 (11): 78–84.
9. Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leuk Lymphoma 2003; 44 (Suppl. 3): S41–7.
10. Pescarmona E, De Sanctis V et al. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas. J Pathol 1997; 183 (3): 281–6.
11. Ohshima K, Kawasaki C, Muta H et al. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology 2001; 39 (2): 156–62.
12. Xu Y, McKenna RW, Doolittle JE et al. The t(14;18) in diffuse large B-cell lymphoma: correlation with germinal center-associated markers and clinical features. Appl Immunohistochem Mol Morphol 2005; 13 (2): 116–23.
13. Wright George, Bruce Tan et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. PNAS 2003; 100 (17): 9991–6.
14. Wu G, Keating A. Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma. Cancer 2006; 106 (2): 247–57.
15. Monti Stefano, Kerry J.Margaret A. Shipp et al.Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105 (5): 1851–61.
16. Бабичева Л.Г. Факторы прогноза при диффузной В-клеточной крупноклеточной лимфоме. Дис. ... канд. мед. наук. М.: ГУ РОНЦ им. Н.Н. Блохина РАМН, 2005.
17. Terol MJ, Tormo M, Martinez-Climent JA et al. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome. Ann Oncol 2003; 14: 467–74.
18. Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 2005; 106 (4): 1164–74.
19. Elstrom R, Liang Guan et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101 (10): 3875–6.
20. Bain BJ et al. Bone marrow pathology. Blackwell Science Ltd, London: 2001.
21. Bain BJ. Bone marrow trephine biopsy. J Clin Pathol 2001; 54: 737–42.
22. Чигринова Е.В., Павловская А.И., Тупицын Н.Н. Роль иммунофенотипирования в диагностике опухолевого поражения костного мозга при В-клеточных неходжкинских лимфомах. Иммунология гемопоэза. М.: Издательская группа ГУ РОНЦ им Н.Н.Блохина РАМН. 2006; с. 91–117.
23. Falko F, Quintanilla-Martinez L et al. Composite Low Grade B-Cell Lymphomas with Two Immunophenotypically Distinct Cell Populations Are True Biclonal Lymphomas. American Journal of Pathology 1999; 154 (6): 1857–66.
24. Тупицын Н.Н. Иммунологическая диагностика лимфом. Руководство по иммуногистохимической диагностике опухолей человека. М.: Титул, 2004; c. 246–73.
Авторы
Е.В.Чигринова, А.И.Павловская, Н.Н.Тупицын
ГУ РОНЦ им. Н.Н.Блохина РАМН, Москва
ГУ РОНЦ им. Н.Н.Блохина РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.